September 18, 2025Journal of Cancer and Tumor International

Lung Cancer in Non-Smokers: Integrating Histopathological Patterns, Molecular Profiles and Therapeutic Strategies

View Full Paper

Ask AI

Bookmark

Non-smoker lung cancer is characterized by well-differentiated adenocarcinoma, which constitutes 85-90% of cases compared to 40-50% in smokers.
Immunohistochemical analysis reveals TTF-1 expression significantly higher in non-smokers at 80-90%, compared to 60-70% in smokers.
Molecular profiling shows EGFR mutations occur in 40-50% of cases in non-smokers, contrasting with just 10-15% in smokers.
Integrated analysis of histopathological and molecular data is essential for accurate diagnosis and effective treatment planning for non-smoker lung cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Literature review highlights unique histopathological patterns and molecular profiles in non-smoker lung cancer, suggesting tailored therapeutic strategies.

Cite This Study

Ubah et al. (2025) studied this question.

synapsesocial.com/papers/68d433aa713b0b5dfea73252 https://doi.org/10.9734/jcti/2025/v15i4324

View Full Paper

Ask AI

Bookmark

Implication

Literature review highlights unique histopathological patterns and molecular profiles in non-smoker lung cancer, suggesting tailored therapeutic strategies.

Lung Cancer in Non-Smokers: Integrating Histopathological Patterns, Molecular Profiles and Therapeutic Strategies

Key Points

Discussion

Implication

Cite This Study

Lung Cancer in Non-Smokers: Integrating Histopathological Patterns, Molecular Profiles and Therapeutic Strategies

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider